Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

Engraftment Syndrome after Autologous Stem Cell Transplant: Retrospective Review in Patients with Multiple Myeloma

Completed

Looking for future studies?

Key information

Conditions

Multiple Myeloma Blood Protein Disorders Cardiovascular Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Immune System Diseases Immunoproliferative Disorders Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Neoplasms, Plasma Cell Paraproteinemias Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

About this study

A retrospective chart review series will be performed fpr subjects enrolled from 1/1/2006.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with Multiple Myeloma, developing engraftment syndrome

Exclusion criteria

Patients with Multiple Myeloma, with no features of engraftment syndrome

Treatment and study plan

Primary outcomes

number of patients developing Engraftment syndrome following stem cell transplant

Time frame: 6 months post-transplant

A retrospective review where subjects medical records are studied for development of engraftment syndrome 6 months after stem cell transplant

Sponsors and collaborators

Lead sponsor

University of Arkansas

Other

Registry information

Important dates

Study start: 2006
Primary completion: 2013
Study completion: 2013
First posted: Jun 19, 2012
Registry last updated: Mar 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed